Unable to load price data. Sorry.

¯\_(ツ)_/¯

Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: No stars

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:BRLI will perform against the market?

Add Stock to CAPS Watchlist

All Players

255 Outperform
17 Underperform
 

All-Star Players

43 Outperform
2 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top NASDAQ:BRLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

debster863 (< 20)
Submitted March 04, 2011

I work in Healthcare, this lab has just come into our organization, we currently use labcorp and quest. I started researching bio-referance and it seems a strong company. lots of positives (growth, gendx, cancer research etc). still researching but… More

ac11166 (< 20)
Submitted August 29, 2006

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

NASDAQ:BRLI VS S&P 500 (SPY)

Fools bullish on NASDAQ:BRLI are also bullish on:

Fools bearish on NASDAQ:BRLI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BRLI.

Recs

0
Member Avatar MWillou (32.72) Submitted: 12/20/2013 9:30:14 AM : Outperform Start Price: $25.20 NASDAQ:BRLI Score: -28.13

Near-term ACA pressure will negatively impact BRLI and the other healthcare provider (health system, clinical labs) companies. Several years out, I expect BRLI to increase because it performs esoteric tests that DGX and LH do not. Game changer in lab industry is Theranos, who is not doing esoteric testing right now.

Recs

0
Member Avatar tecramer (< 20) Submitted: 9/2/2013 8:33:18 PM : Outperform Start Price: $29.29 NASDAQ:BRLI Score: -62.77

This small player has lots of room to grow with some innovative tests and interesting acquisitions that should help expand market share along with geographic coverage.

Recs

0
Member Avatar cheezyches (97.19) Submitted: 4/16/2013 8:19:16 AM : Outperform Start Price: $23.76 NASDAQ:BRLI Score: -45.61

BRLI is operating in a long-term trend of increasing health care. It's financial results have shown robust growth trajectories over the last few years. I do not see any reason for this trend to change.

Leaderboard

Find the members with the highest scoring picks in BRLI.

Score Leader

avscaptain

avscaptain (89.64) Score: +134.56

The Score Leader is the player with the highest score across all their picks in BRLI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pnouri 92.56 7/27/2010 Underperform 5Y $21.79 +58.83% +166.52% +107.68 0 Comment
williamscaps 27.07 10/25/2010 Underperform 5Y $22.99 +50.54% +150.64% +100.10 1 Comment
buckler9483 62.27 9/8/2010 Underperform 5Y $19.63 +76.31% +170.30% +93.99 0 Comment
bigreenmountain 83.02 1/23/2007 Outperform 3Y $11.22 +208.60% +123.05% +85.56 0 Comment
jaystox < 20 6/20/2012 Underperform 5Y $25.63 +35.04% +120.29% +85.25 0 Comment
dsks68 < 20 8/28/2006 Outperform 3Y $10.46 +230.88% +145.78% +85.10 1 Comment
kd554 < 20 8/28/2006 Outperform 1Y $10.46 +230.88% +145.78% +85.10 0 Comment
tomkat104 27.36 8/29/2006 Outperform 5Y $10.53 +228.68% +145.42% +83.26 0 Comment
PapaMan200 93.98 8/29/2006 9/7/2006 Outperform 5Y $10.53 +228.68% +145.97% +82.71 0 Comment
NetscribeHealthC 56.16 1/31/2007 Outperform 1Y $11.39 +203.86% +122.47% +81.39 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.41 11/1/2012 Outperform 3W $28.13 +23.04% +109.30% -86.27 0 Comment
TrackBofASec 91.74 6/12/2012 Outperform NS $22.88 +28.50% +24.98% +3.52 6/17/2013 @ $29.40 0 Comment
TrackUBS 89.81 7/8/2010 Outperform NS $20.99 +64.89% +181.18% -116.29 0 Comment
TrackTheBenchmar 79.95 6/17/2010 Outperform NS $23.44 +47.65% +166.25% -118.60 0 Comment
TrackOppenheimer < 20 5/29/2008 Outperform NS $12.67 -3.63% -35.19% +31.56 1/9/2009 @ $12.21 0 Comment
TrackWMBlair 73.77 2/21/2008 Outperform NS $14.46 +139.39% +129.11% +10.28 0 Comment
TrackJefferies 75.27 1/16/2007 Outperform NS $11.87 +23.46% -33.35% +56.82 6/5/2009 @ $14.66 0 Comment
TrackJimCramer 86.41 12/20/2006 Underperform 3W $11.49 +144.82% +0.53% -144.30 11/1/2012 @ $28.13 0 Comment